Skip to main content
Produced by W2D1 Media. Work with us →

About b.next

b.next is a San Francisco biotechnology company developing the tools and infrastructure to build synthetic cells from scratch. It launched and maintains Nucleus, an open platform of materials, protocols and software for cell building, and works with university labs, government agencies and philanthropic funders. It launched in 2023 and is led by chief executive Akshay Maheshwari and chief technology officer Anton Jackson-Smith.

Business model
Biotech (synthetic cell platform + grants)
Founders
Akshay Maheshwari
Headquarters
San Francisco

Sources: bnext.bio, bnext.bio

The people on Day One.

Hear from the team.

Spot something wrong? Suggest a correctionUpdated 29 October 2026

Be part of
the conversation.

Put your brand alongside the voices founders, investors and operators come to hear.

Explore sponsorship

Want a show like this for your fund or company?

We're W2D1 Media — the team behind the Day One Network, and we helped build Blackbird Ventures' Wild Hearts. We turn podcasts into trust, authority and pipeline.

Book a call →